- Home
- GLPG vs STEW Comparison
GLPG vs STEW Comparison
Compare GLPG & STEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- STEW
- Stock Information
- Founded
- GLPG 1999
- STEW 1972
- Country
- GLPG Belgium
- STEW United States
- Employees
- GLPG N/A
- STEW N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- STEW Investment Managers
- Sector
- GLPG Health Care
- STEW Finance
- Exchange
- GLPG Nasdaq
- STEW Nasdaq
- Market Cap
- GLPG 1.8B
- STEW 1.6B
- IPO Year
- GLPG 2005
- STEW N/A
- Fundamental
- Price
- GLPG $27.87
- STEW $17.56
- Analyst Decision
- GLPG Sell
- STEW
- Analyst Count
- GLPG 4
- STEW 0
- Target Price
- GLPG $25.33
- STEW N/A
- AVG Volume (30 Days)
- GLPG 259.2K
- STEW 84.5K
- Earning Date
- GLPG 07-23-2025
- STEW 01-01-0001
- Dividend Yield
- GLPG N/A
- STEW 3.71%
- EPS Growth
- GLPG N/A
- STEW N/A
- EPS
- GLPG N/A
- STEW 1.44
- Revenue
- GLPG $311,493,731.00
- STEW N/A
- Revenue This Year
- GLPG $0.78
- STEW N/A
- Revenue Next Year
- GLPG N/A
- STEW N/A
- P/E Ratio
- GLPG N/A
- STEW $10.34
- Revenue Growth
- GLPG 18.32
- STEW N/A
- 52 Week Low
- GLPG $22.36
- STEW $11.97
- 52 Week High
- GLPG $31.23
- STEW $14.94
- Technical
- Relative Strength Index (RSI)
- GLPG 51.86
- STEW 53.60
- Support Level
- GLPG $26.62
- STEW $17.10
- Resistance Level
- GLPG $29.28
- STEW $17.40
- Average True Range (ATR)
- GLPG 0.58
- STEW 0.17
- MACD
- GLPG -0.16
- STEW 0.01
- Stochastic Oscillator
- GLPG 54.51
- STEW 69.79
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About STEW SRH Total Return Fund Inc.
SRH Total Return Fund, Inc. is a non-diversified closed-end management investment company. The company's investment objective is to seek total returns. Its fund utilizes a bottom-up, value-driven investment process to identify securities of good quality businesses trading below estimated intrinsic value. The Funds are available as an actively-managed closed-end fund, an actively managed ETF and a passively-managed ETF.